Ascendis Pharma A/S

Search
⚲

Ascendis Pharma A/S
Ticker	ASND
CIK #	0001612042
CUSIP	04351P101
Sector	Life Sciences - Pharmaceutical Preparations
Address	Tuborg Boulevard 5, Hellerup, DK-2900
Source	[EDGAR]

CIK	Filing	2011 - 2024
[0001612042]	6-K
[0001612042]	D
[0001612042]	SC 13D
[0001612042]	SC 13G

Form 13D/13G Filer	Form 13D/13G Subject	Filed	% Owned
Avoro Capital Advisors LLC	Ascendis Pharma A/S	[2023-02-14]	5.4
Westfield Capital Management Co LP	Ascendis Pharma A/S	[2023-02-02]	5.54
Janus Henderson Group PLC	Ascendis Pharma A/S	[2021-02-12]	5.6
Wellington Management Group LLP	Ascendis Pharma A/S	[2021-02-03]	6.45
Artisan Partners Limited Partnership	Ascendis Pharma A/S	[2020-10-08]	10.5
Price T Rowe Associates Inc /MD/	Ascendis Pharma A/S	[2019-02-14]	9.7
EcoR1 Capital LLC	Ascendis Pharma A/S	[2018-02-14]	5.8
Baker Bros Advisors LP	Ascendis Pharma A/S	[2018-02-13]	7.1
FMR LLC	Ascendis Pharma A/S	[2016-02-12]	0.0
Gilde Healthcare Holding BV	Ascendis Pharma A/S	[2016-02-09]	7.4
Sofinnova Capital V FCPR	Ascendis Pharma A/S	[2015-09-10]	11.0
Visium Asset Management LP	Ascendis Pharma A/S	[2015-08-31]	5.2
RA Capital Management LLC	Ascendis Pharma A/S	[2015-05-08]	6.0
Vivo Ventures VII LLC	Ascendis Pharma A/S	[2015-02-17]	5.1
OrbiMed Advisors LLC	Ascendis Pharma A/S	[2015-02-12]	6.1
Sofinnova Venture Partners IX LP	Ascendis Pharma A/S	[2015-02-06]	11.0

Form 13F Holdings
Firm	Period	DFND	Voting	Shares
RA Capital Management LP	[2023-03-31]	SOLE	0.0	6,957,179.0
Artisan Partners Limited Partnership	[2023-03-31]	SOLE	5,838,904.0	6,844,741.0
FMR LLC	[2023-03-31]	DFND	5,151,804.0	5,152,165.0
Janus Henderson Group PLC	[2023-03-31]	DFND	0.0	3,532,830.0
T. Rowe Price Investment Management, Inc.	[2023-03-31]	SOLE	1,336,255.0	3,473,466.0
Price T Rowe Associates Inc /MD/	[2023-03-31]	SOLE	1,073,099.0	3,369,943.0
Avoro Capital Advisors LLC	[2023-03-31]	SOLE	3,325,000.0	3,325,000.0
Westfield Capital Management Co LP	[2023-03-31]	SOLE	2,775,516.0	3,146,126.0
Wellington Management Group LLP	[2023-03-31]	DFND	0.0	2,933,792.0
Goldman Sachs Group Inc	[2023-03-31]	DFND	2,625,145.0	2,625,145.0
Capital International Investors	[2023-03-31]	DFND	1,989,106.0	1,989,106.0
Franklin Resources Inc	[2023-03-31]	DFND	1,345,904.0	1,345,904.0
Massachusetts Financial Services Co /MA/	[2023-03-31]	SOLE	1,213,493.0	1,213,493.0
TimesSquare Capital Management LLC	[2023-03-31]	SOLE	725,455.0	852,080.0
Eventide Asset Management LLC	[2023-03-31]	SOLE	782,840.0	782,840.0
Point72 Asset Management LP	[2023-03-31]	DFND	0.0	771,110.0
Sofinnova Investments Inc	[2023-03-31]	SOLE	754,032.0	754,032.0
Putnam Investments LLC	[2023-03-31]	DFND	740,862.0	740,862.0
Spyglass Capital Management LLC	[2023-03-31]	SOLE	713,966.0	713,966.0
Invesco Ltd.	[2023-03-31]	DFND	0.0	646,560.0
AllianceBernstein LP	[2023-03-31]	DFND	474,075.0	515,058.0
Adage Capital Partners GP LLC	[2023-03-31]	SOLE	500,000.0	500,000.0
Caption Management LLC	[2023-03-31]	SOLE	484,600.0	484,600.0
SEI Investments Co	[2023-03-31]	SOLE	476,021.0	476,021.0
Brown Advisory Inc	[2023-03-31]	DFND	399,582.0	466,372.0
Rock Springs Capital Management LP	[2023-03-31]	SOLE	425,500.0	425,500.0
BlackRock Inc.	[2023-03-31]	SOLE	379,699.0	381,099.0
Deutsche Bank AG	[2023-03-31]	DFND	365,488.0	365,488.0
American Century Companies Inc	[2023-03-31]	DFND	179,644.0	356,637.0
Paradigm Biocapital Advisors LP	[2023-03-31]	SOLE	350,866.0	350,866.0
Prev \| Page 1 \| Next

{"search": "/search", "clicked": "/clicked", "portfolio_add": "/portfolio-add", "portfolio_remove": "/portfolio-remove", "portfolio_create": "/portfolio-create", "portfolio_activate": "/portfolio-activate", "portfolio_delete": "/portfolio-delete", "portfolio_rename": "/portfolio-rename", "portfolio_color": "/portfolio-color", "home_filter": "/home-filter", "htmlspeed": "/htmlspeed", "add_tag_firm": "/add-tag-firm", "add_tag_click": "/add-tag-click", "copy_aum": "/copy-aum", "stripe_checkout": "/stripe-checkout", "update_card": "/update-card"}

Ascendis Pharma A/S

Stock Issuer and Owners